| Dr Michael Anthony Avallone, MD | |
|
12605 E 16th Ave, Aurora, CO 80045-2545 | |
| (720) 848-0000 | |
| Not Available |
| Full Name | Dr Michael Anthony Avallone |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 12 Years |
| Location | 12605 E 16th Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013273036 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | DR.0058294 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marian Regional Medical Center | Santa maria, CA | Hospital |
| Lompoc Valley Medical Center | Lompoc, CA | Hospital |
| French Hospital Medical Center | San luis obispo, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urology Associates Of The Central Coast | 4486750049 | 10 |
News Archive
As the coronavirus disease (COVID-19) continues to wreak havoc across the globe, it has been thought that children mostly seemed to be spared by severe illness. In the majority of cases, children infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) only develop a mild illness, with some tagged as asymptomatic.
Anesthesia & Analgesia, the official journal of the International Anesthesia Research Society (IARS), reports continued increase in its Impact Factor, the rating of academic and scientific journals tracked and published annually by Thomson Reuters.
Onyx Pharmaceuticals, Inc. today announced results from the Phase 3 trial GRID (GIST – Regorafenib in Progressive Disease) evaluating the investigational compound regorafenib (BAY 73-4506), a Bayer-owned compound, for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib.
AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.
Successful aging means more than good health. It means taking charge of your personal wellbeing so that you can continue to live a vibrant, independent life, regardless of your age, according to Dr. Terri Ginsberg of the New Jersey Institute for Successful Aging at the UMDNJ-School of Osteopathic Medicine.
› Verified 5 days ago
| Entity Name | Urology Associates Of The Central Coast |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881785764 PECOS PAC ID: 4486750049 Enrollment ID: O20070428000115 |
News Archive
As the coronavirus disease (COVID-19) continues to wreak havoc across the globe, it has been thought that children mostly seemed to be spared by severe illness. In the majority of cases, children infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) only develop a mild illness, with some tagged as asymptomatic.
Anesthesia & Analgesia, the official journal of the International Anesthesia Research Society (IARS), reports continued increase in its Impact Factor, the rating of academic and scientific journals tracked and published annually by Thomson Reuters.
Onyx Pharmaceuticals, Inc. today announced results from the Phase 3 trial GRID (GIST – Regorafenib in Progressive Disease) evaluating the investigational compound regorafenib (BAY 73-4506), a Bayer-owned compound, for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib.
AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.
Successful aging means more than good health. It means taking charge of your personal wellbeing so that you can continue to live a vibrant, independent life, regardless of your age, according to Dr. Terri Ginsberg of the New Jersey Institute for Successful Aging at the UMDNJ-School of Osteopathic Medicine.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Anthony Avallone, MD Po Box 110429, Aurora, CO 80042-0429 Ph: (303) 493-7000 | Dr Michael Anthony Avallone, MD 12605 E 16th Ave, Aurora, CO 80045-2545 Ph: (720) 848-0000 |
News Archive
As the coronavirus disease (COVID-19) continues to wreak havoc across the globe, it has been thought that children mostly seemed to be spared by severe illness. In the majority of cases, children infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) only develop a mild illness, with some tagged as asymptomatic.
Anesthesia & Analgesia, the official journal of the International Anesthesia Research Society (IARS), reports continued increase in its Impact Factor, the rating of academic and scientific journals tracked and published annually by Thomson Reuters.
Onyx Pharmaceuticals, Inc. today announced results from the Phase 3 trial GRID (GIST – Regorafenib in Progressive Disease) evaluating the investigational compound regorafenib (BAY 73-4506), a Bayer-owned compound, for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib.
AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer´s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS´ AFFITOME® technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.
Successful aging means more than good health. It means taking charge of your personal wellbeing so that you can continue to live a vibrant, independent life, regardless of your age, according to Dr. Terri Ginsberg of the New Jersey Institute for Successful Aging at the UMDNJ-School of Osteopathic Medicine.
› Verified 5 days ago
Dr. Janine L Oliver, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-1800 | |
Brian Flynn, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Granville L Lloyd, MD Urology Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, University Of Colorado Hospital, Aurora, CO 80045 Phone: 720-848-0000 | |
Vijaya Vemulakonda, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Brian Thomas Caldwell, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Box 463, Aurora, CO 80045 Phone: 720-777-1234 | |
Eric Christian Ballon-landa, MD Urology Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |